Novel 4-Anilinopyrimidine-N-Acylhydrazone derivatives as dual EGFR(WT)/VEGFR-2 tyrosine kinase inhibitors against non-small cell lung Cancer: Design, synthesis, biological evaluation, and computational studies.
- DOI
- 10.1016/j.bioorg.2026.110719
- Published
- 2026 Nov 5
- Container
- Bioorganic chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bioorg.2026.110719,
title = {Novel 4-Anilinopyrimidine-N-Acylhydrazone derivatives as dual EGFR(WT)/VEGFR-2 tyrosine kinase inhibitors against non-small cell lung Cancer: Design, synthesis, biological evaluation, and computational studies.},
author = {Ibrahim TH and Kadry HH and Mohamed KO and Loksha YM and Nasrallah RS and Nemr MTM},
year = {2026},
journal = {Bioorganic chemistry},
doi = {10.1016/j.bioorg.2026.110719},
url = {https://doi.org/10.1016/j.bioorg.2026.110719}
}RIS
TY - JOUR TI - Novel 4-Anilinopyrimidine-N-Acylhydrazone derivatives as dual EGFR(WT)/VEGFR-2 tyrosine kinase inhibitors against non-small cell lung Cancer: Design, synthesis, biological evaluation, and computational studies. AU - Ibrahim TH AU - Kadry HH AU - Mohamed KO AU - Loksha YM AU - Nasrallah RS AU - Nemr MTM PY - 2026 JO - Bioorganic chemistry DO - 10.1016/j.bioorg.2026.110719 UR - https://doi.org/10.1016/j.bioorg.2026.110719 ER -
APA
TH, I., HH, K., KO, M., YM, L., RS, N., & MTM, N. (2026). Novel 4-Anilinopyrimidine-N-Acylhydrazone derivatives as dual EGFR(WT)/VEGFR-2 tyrosine kinase inhibitors against non-small cell lung Cancer: Design, synthesis, biological evaluation, and computational studies.. Bioorganic chemistry. https://doi.org/10.1016/j.bioorg.2026.110719
Source records
- pubmed · retrieved 2026-11-10T11:04:05.965Z